Cinchocaine
Standardized Chemical Allergen — CARDIOVASCULAR SYSTEM
Also known as: dermacaine, dibucaine, dibucaine HCl, dibucaine hydrochloride, nupercaine, percamine
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Cinchocaine is an ofm drug in the Standardized Chemical Allergen class catalogued in DrugCentral. DrugCentral lists 3 molecular targets, including SCN1A|SCN2A|SCN3A, SCN5A and SCN10A. Recorded indications include Itching of skin, Minor Skin Wound Pain and Skin irritation.
- Approval status: ofm.
- Drug class: Standardized Chemical Allergen.
- Molecular targets: SCN1A|SCN2A|SCN3A, SCN5A and SCN10A (3 listed in DrugCentral).
- Indications: Itching of skin, Minor Skin Wound Pain and Skin irritation.
- ATC code: C05AD04 (Local anesthetics).
- Molecular formula: C20H29N3O2; molecular weight 343.47 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (3)
- Itching of skin
- Minor Skin Wound Pain
- Skin irritation
Contraindications (12)
- Bleeding hemorrhoids
- Conduction disorder of the heart
- Decreased respiratory function
- Deficiency of cholinesterase
- Denuded skin
- Disease of liver
- Disorder of cardiovascular system
- Disorder of mucous membrane
- Kidney disease
- Myasthenia gravis
- Open wound
- Seizure disorder
Mechanism & targets
| Established pharmacologic class | Standardized Chemical Allergen |
|---|
Molecular targets (3)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Sodium channel alpha subunits; brain (Types I, II, III) | SCN1A|SCN2A|SCN3A | unknown | IC50 5.85 |
| Sodium channel protein type 5 subunit alpha | SCN5A | blocker | — |
| Sodium channel protein type 10 subunit alpha | SCN10A | blocker | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| — | FDA | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
C05AD04 | CARDIOVASCULAR SYSTEM › VASOPROTECTIVES › AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE › Local anesthetics |
D04AB02 | DERMATOLOGICALS › ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. › ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. › Anesthetics for topical use |
N01BB06 | NERVOUS SYSTEM › ANESTHETICS › ANESTHETICS, LOCAL › Amides |
S01HA06 | SENSORY ORGANS › OPHTHALMOLOGICALS › LOCAL ANESTHETICS › Local anesthetics |
S02DA04 | SENSORY ORGANS › OTOLOGICALS › OTHER OTOLOGICALS › Analgesics and anesthetics |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Heart sounds | 125.7 |
| Prolonged expiration | 118.8 |
| Depressive symptom | 84.8 |
| Respiration abnormal | 80.8 |
| Appetite disorder | 80.7 |
| Flank pain | 65.8 |
| Rales | 65.3 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Cinchocaine is on its molecule page.
| Molecular formula | C20H29N3O2 |
|---|---|
| Molecular weight | 343.47 g/mol |
| CAS number | 85-79-0 |
| InChIKey | PUFQVTATUTYEAL-UHFFFAOYSA-N |
| PubChem CID | 3025 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Cinchocaine used for?
DrugCentral lists the following indications for Cinchocaine: Itching of skin, Minor Skin Wound Pain and Skin irritation.
How does Cinchocaine work?
Its molecular targets in DrugCentral include SCN1A|SCN2A|SCN3A, SCN5A (blocker) and SCN10A (blocker).
What drug class does Cinchocaine belong to?
Cinchocaine is in the Standardized Chemical Allergen class.
What is the chemical formula of Cinchocaine?
Cinchocaine has the molecular formula C20H29N3O2 and a molecular weight of 343.47 g/mol.
Browse: all drugs starting with C · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 859 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1086 — compound record and bioactivity
- PubChem CID 3025 — chemical identifiers
- DrugBank DB00527 — drug record
- FDA UNII L6JW2TJG99 — substance identity
- DailyMed: FDA labels for Cinchocaine — current prescribing information (label search)
- UniProt Q14524 (SCN5A) — target protein
- UniProt Q9Y5Y9 (SCN10A) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.